$TWSI NEWS OUT!!! HemCon Medical Technologies R
Post# of 3568
Posted On: 03/24/2014 8:55:58 AM
[b]$TWSI NEWS OUT!!![/b]
HemCon Medical Technologies Revenue Growth Surges in Japan
Print
Alert
Tristar Wellness Solutions Inc. (QB) (USOTC:TWSI)
Intraday Stock Chart
Today : Monday 24 March 2014
Click Here for more Tristar Wellness Solutions Inc. (QB) Charts.
WESTPORT, Conn., March 24, 2014 /PRNewswire/ -- HemCon Medical Technologies, Inc. ("HemCon"), a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today significant sales growth and momentum for the HemCon hemostatic product line in Japan. Sales for the first quarter of 2014 exceed overall sales for the previous year, and are trending to bring significant growth for the remainder of the year. This growth is fueled by new focus on sales and marketing efforts of HemCon's exclusive partner in Japan, Zeria Pharmaceuticals Ltd. Co. (Zeria), who has worked with the HemCon product line since 2010, ensuring the current and newly developed products become the standard of care for hemostasis in the country. Japan has the third largest global woundcare market, estimated to growth to $2.3B by 2016[1].
The HemCon products are relevant solutions for the Japanese healthcare needs, with focus on cardiac catheterization, emergency care, woundcare, hemodialysis and oral surgery; HemCon products provide superior bleeding control through their proprietary raw material formulation of chitosan. Innovative and efficacious HemCon products, paired with the specific market intelligence and know-how from Zeria will also ensure the companies continue to improve medical device innovation through exciting new product introductions planned for the upcoming year.
"We are encouraged by the success we have seen in this first quarter," said William Perrin, HemCon's Japan Representative, "We are well positioned to continue with a strong sales effort and expect 2014 to be a very momentous year, which puts us in an excellent position to increase the HemCon product offerings in Japan."
About HemCon Medical Technologies
HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. With a 36,000 sq. ft. state of the art manufacturing facility, the Company has additional commercial operations in Ireland and the Czech Republic. For more information, please visit www.hemcon.com.
About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (TWSI) is a health and wellness company that targets under-met consumer opportunities in the OTC and professional marketplace. Its core strategy plans to meet the growing demand for personalized, care solutions by leveraging proprietary innovation and healthcare technology with the rapid transformation of the healthcare marketplace to create innovative, science based solutions and brands. TriStar recently acquired HemCon Medical Technologies Inc., a developer, manufacturer, and marketer of innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. It also owns the Beaute de Maman(TM) brand of women's health products. Additional information is available at www.tstarwellness.com.
Forward-Looking Statement
This press release for TriStar Wellness Solutions®, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like "anticipates," "believes," "expects," "future," "intends," "plans," and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.
Contact:
Simona Buergi
Tel: (503) 245-0459
simona.buergi@hemcon.com
HemCon Medical Technologies Revenue Growth Surges in Japan
Alert
Tristar Wellness Solutions Inc. (QB) (USOTC:TWSI)
Intraday Stock Chart
Today : Monday 24 March 2014
Click Here for more Tristar Wellness Solutions Inc. (QB) Charts.
WESTPORT, Conn., March 24, 2014 /PRNewswire/ -- HemCon Medical Technologies, Inc. ("HemCon"), a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today significant sales growth and momentum for the HemCon hemostatic product line in Japan. Sales for the first quarter of 2014 exceed overall sales for the previous year, and are trending to bring significant growth for the remainder of the year. This growth is fueled by new focus on sales and marketing efforts of HemCon's exclusive partner in Japan, Zeria Pharmaceuticals Ltd. Co. (Zeria), who has worked with the HemCon product line since 2010, ensuring the current and newly developed products become the standard of care for hemostasis in the country. Japan has the third largest global woundcare market, estimated to growth to $2.3B by 2016[1].
The HemCon products are relevant solutions for the Japanese healthcare needs, with focus on cardiac catheterization, emergency care, woundcare, hemodialysis and oral surgery; HemCon products provide superior bleeding control through their proprietary raw material formulation of chitosan. Innovative and efficacious HemCon products, paired with the specific market intelligence and know-how from Zeria will also ensure the companies continue to improve medical device innovation through exciting new product introductions planned for the upcoming year.
"We are encouraged by the success we have seen in this first quarter," said William Perrin, HemCon's Japan Representative, "We are well positioned to continue with a strong sales effort and expect 2014 to be a very momentous year, which puts us in an excellent position to increase the HemCon product offerings in Japan."
About HemCon Medical Technologies
HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. With a 36,000 sq. ft. state of the art manufacturing facility, the Company has additional commercial operations in Ireland and the Czech Republic. For more information, please visit www.hemcon.com.
About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (TWSI) is a health and wellness company that targets under-met consumer opportunities in the OTC and professional marketplace. Its core strategy plans to meet the growing demand for personalized, care solutions by leveraging proprietary innovation and healthcare technology with the rapid transformation of the healthcare marketplace to create innovative, science based solutions and brands. TriStar recently acquired HemCon Medical Technologies Inc., a developer, manufacturer, and marketer of innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. It also owns the Beaute de Maman(TM) brand of women's health products. Additional information is available at www.tstarwellness.com.
Forward-Looking Statement
This press release for TriStar Wellness Solutions®, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like "anticipates," "believes," "expects," "future," "intends," "plans," and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.
Contact:
Simona Buergi
Tel: (503) 245-0459
simona.buergi@hemcon.com
(0)
(0)Scroll down for more posts ▼